UnitedHealth Group (NYSE:UNH – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Truist Financial in a research note issued to investors on Thursday, Benzinga reports. They currently have a $610.00 target price on the healthcare conglomerate’s stock. Truist Financial’s target price would suggest a potential upside of 11.48% from the stock’s previous close.
A number of other equities analysts also recently commented on UNH. StockNews.com downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 21st. Stephens restated an “overweight” rating and set a $585.00 target price on shares of UnitedHealth Group in a report on Thursday. Jefferies Financial Group lowered their price target on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating on the stock in a research report on Monday, November 20th. Morgan Stanley decreased their target price on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a report on Monday, October 23rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday. Two equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $579.65.
View Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Trading Down 0.7 %
UNH opened at $547.16 on Thursday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.80 and a quick ratio of 0.80. UnitedHealth Group has a 12-month low of $445.68 and a 12-month high of $554.70. The firm’s fifty day moving average price is $530.57 and its 200 day moving average price is $502.05. The stock has a market capitalization of $506.08 billion, a PE ratio of 23.75, a P/E/G ratio of 1.62 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.33 by $0.23. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.58%. The firm had revenue of $92.36 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the prior year, the firm posted $5.79 EPS. UnitedHealth Group’s revenue was up 14.2% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group will post 24.94 EPS for the current fiscal year.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total value of $2,448,171.44. Following the completion of the sale, the executive vice president now owns 9,218 shares in the company, valued at approximately $5,017,173.04. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other UnitedHealth Group news, Director Stephen J. Hemsley sold 121,515 shares of the stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $540.58, for a total transaction of $65,688,578.70. Following the sale, the director now directly owns 521,818 shares in the company, valued at approximately $282,084,374.44. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 4,498 shares of the firm’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $544.28, for a total value of $2,448,171.44. Following the completion of the transaction, the executive vice president now owns 9,218 shares in the company, valued at $5,017,173.04. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On UnitedHealth Group
Institutional investors and hedge funds have recently bought and sold shares of the business. B. Riley Wealth Advisors Inc. increased its stake in UnitedHealth Group by 10.0% during the third quarter. B. Riley Wealth Advisors Inc. now owns 55,695 shares of the healthcare conglomerate’s stock worth $28,081,000 after acquiring an additional 5,074 shares during the last quarter. Wellington Management Group LLP increased its stake in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. American Century Companies Inc. boosted its position in shares of UnitedHealth Group by 2.3% during the third quarter. American Century Companies Inc. now owns 2,929,147 shares of the healthcare conglomerate’s stock valued at $1,476,847,000 after buying an additional 65,362 shares during the period. Fidelity D & D Bancorp Inc. purchased a new position in UnitedHealth Group during the 3rd quarter worth $202,000. Finally, Modera Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 4.3% in the 3rd quarter. Modera Wealth Management LLC now owns 39,737 shares of the healthcare conglomerate’s stock valued at $20,035,000 after acquiring an additional 1,646 shares during the period. 85.69% of the stock is owned by institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
